Individuals with vitiligo did not display a significantly increased risk for cancer compared with the general population, according to a study. People with first-degree relatives who were ...

An FDA safety announcement regarding labeling changes for the commonly used oncology drugs capecitabine and 5-fluorouracil highlights a risk of dihydropyrimidine dehydrogenase deficiency, which can ...

Hematology-Oncology Associates of CNY has appointed Jennifer Pichoske as chief executive officer effective February 15, 2025. She succeeds Maryann Roefaro who was CEO since 2002 and is retiring. >> ...

She earned her medical degree from Cornell University Medical College in New York, completed her internal medicine residency ...

Panelists discuss how they envision the future of industry-provided and other patient support services in hematology-oncology, highlighting potential improvements and innovations that could be ...